Abstract
Purpose
The purpose of the study was to prospectively evaluate safety and effectiveness of percutaneous microwave ablation under temperature monitoring assisted with ethanol injection for liver cancer abutting gastrointestinal tract.
Materials and Methods
One hundred seventy-nine hepatic tumors that underwent percutaneous microwave ablation with curative intention were included. Fifty-three lesions located less than 5 mm from gastrointestinal tract were in gastrointestinal group. One hundred twenty-six lesions located more than 5 mm from hepatic surface and first or second branch of hepatic vessels were in control group. The temperature of marginal ablation tissue proximal to gastrointestinal tract was monitored and controlled to fluctuating between 45°C and 58°C for more than 10 min for tumors in the gastrointestinal group. Ethanol (2–27 ml) was injected into marginal tissue in 33 of 53 lesions of the GI group.
Results
Forty-seven of 53 tumors (88.7%) in the gastrointestinal group and 116 of 126 tumors (92.1%) in the control group achieved complete ablation (p > 0.05). There were neither immediate nor periprocedural complications in both groups. Tumor seeding happened in one of the gastrointestinal group and two of the control group. There was no delayed complication of bile ducts injury.
Conclusion
Under strict temperature monitoring, microwave ablation assisted with ethanol injection is safe and achieves a high complete ablation rate for hepatic tumors adjacent to gastrointestinal tract.
Similar content being viewed by others
Reference
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74–108.
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907–1917. doi:10.1016/S0140-6736(03)14964-1.
Bruix J, Fuster J, Llovet JM. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003;9:700–702. doi:10.1053/jlts.2003.50124.
Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889–896. doi:10.1053/gast.2002.32418.
Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62(Suppl 1):64–68. doi:10.1159/000048278.
Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101–108.
The Liver Cancer Study Group of Japan. Percutaneous ethanol injection therapy for hepatocellular carcinoma: predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772–2780. doi:10.1002/1097-0142(19941115)74:10<2772::AID-CNCR2820741006>3.0.CO;2-V.
Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817–825. doi:10.1002/1097-0142(19940801)74:3<817::AID-CNCR2820740306>3.0.CO;2-8.
Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L et al. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. AJR Am J Roentgenol 1998;171:449–454.
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761–768.
Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759–767.
Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation using multiprobe arrays. Acad Radiol 1995;2:670–674. doi:10.1016/S1076-6332(05)80852-9.
McGahan JP, Gu WZ, Brock JM, Tesluk H, Jones CD. Preliminary investigation: hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 1996;3:418–422. doi:10.1016/S1076-6332(05)80677-4.
Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 2001;26:345–360. doi:10.1007/s002610000194.
Buscarini L, Buscarini E, Stasi MD, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914–921. doi:10.1007/s003300000659.
Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2520 lesions). Radiology 2002;225:367–377. doi:10.1148/radiol.2252011171.
Murakami R, Yoshinatse S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR Am J Roentgenol 1995;164:1159–1164.
Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299–307. doi:10.1148/radiol.2351031944.
Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 2003;180:1547–1555.
Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999;19:323–328.
Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999;85:1694–1702. doi:10.1002/(SICI)1097-0142(19990415)85:8<1694::AID-CNCR8>3.0.CO;2-3.
Matsukawa T, Yamashita Y, Arakawa A, Nishiharu T, Urata J, Murakami R et al. Percutaneous microwave coagulation therapy in liver tumors: a 3-year experience. Acta Radiol 1997;38:410–415.
Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ et al. Hepatocellular carcinoma: sonography-guided percutaneous microwave coagulation therapy. Radiology 2001;221:167–172. doi:10.1148/radiol.2211001783.
Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, International Working Group on Image-Guided Tumor Ablation et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003;228:335–345. doi:10.1148/radiol.2282021787.
Andromanakos N, Filippou D, Papadopoulos V, Kouraklis G, Christianakis E, Kostakis A. New concepts in the therapeutic options of liver metastases from colorectal cancer. J BUON 2007;12:445–452.
Mazzaglia PJ, Berber E, Siperstein AE. Radiofrequency thermal ablation of metastatic neuroendocrine tumors in the liver. Curr Treat Options Oncol 2007;8:322–330. doi:10.1007/s11864-007-0038-9.
Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206–1222. doi:10.1046/j.1365-2168.2002.02168.x.
Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma an analysis of 1000 cases. Cancer 2005;103:1201–1209. doi:10.1002/cncr.20892.
Chopra S, Dodd GD III, Chanin MP, Chintapalli KN. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am J Roentgenol. 2003;180:697–701.
Choi D, Lim HK, Kim MJ, Kim SH, Lee WJ, Kim SH et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract. AJR Am J Roentgenol 2004;183:1417–1424.
Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol 2008;67:357–361. doi:10.1016/j.ejrad.2007.07.015.
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004;127:1714–1723. doi:10.1053/j.gastro.2004.09.003.
Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006;43:1101–1108. doi:10.1002/hep.21164.
Yamakado K, Nakatsuka A, Akeboshi M, Takeda K. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol 2003;14:1183–1186.
Kondo Y, Yoshida H, Shiina S, Tateishi R, Teratani T, Omata M. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br J Surg 2006;93(10):1277–1282. doi:10.1002/bjs.5374.
Goldberg SN, Kruskal JB, Oliver BS, Clouse ME, Gazelle GS. Percutaneous tumor ablation: Increased coagulation by combining radio-frequency ablation and ethanol instillation in a rat breast tumor model. Radiology 2000;217:827–831.
Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007;72(Suppl 1):124–131. doi:10.1159/000111718.
Vallone P, Catalano O, Izzo F, Siani A. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol 2006;29:544–551. doi:10.1007/s00270-005-0173-2.
Acknowledgement
This study was sponsored by National Nature Science Foundation of China (project number 30672016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, P., Liang, P., Yu, X. et al. Percutaneous Microwave Ablation of Liver Cancer Adjacent to the Gastrointestinal Tract. J Gastrointest Surg 13, 318–324 (2009). https://doi.org/10.1007/s11605-008-0710-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-008-0710-9